Dosage Forms

Guy Bouvier, guybouvier06FR@gmail.com, is nonclinical coordination and evaluation manager at Nestle Skin Health. 

Jean-Guy Boiteau is head of process research and development at Nestle Skin Health. 

Amandine Gras is product development coordinator and CMC expert at Nestle Skin Health. 

Anne-Pascale Luzy is head of in vitro toxicology at Nestle Skin Health.

Jean-Pierre Etchegaray is pharmaceutical development expert at Nestle Skin Health.

Articles

The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.

Determination of Dermal PDE for Pharmaceutical Products

Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.

Capsugel Expands Clinical Trial Services at UK Manufacturing Facility

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Ralph Gosden, head of product development at Catalent’s Swindon, United Kingdom site, explains the opportunities of orally disintegrating tablets as a patient-centric dosage form. 


ODTs Dissolve Drug Administration Challenges

Experts from Colorcon share insights on how manufacturers can play a role in minimizing the risk of medication errors by ensuring that the medicines they develop are well differentiated, especially between dosages of the same product.


Reducing Medication Errors

Pharmaceutical companies are increasingly adopting patient-centric formulation development to ensure that drug products adequately meet the needs of end-users in all target patient populations.


Patient Centricity Takes Center Stage

David Vodak, PhD, is senior director at Capsugel’s Bend, Oregon facility.

is head of Solid Form Services at Lonza Pharma & Biotech and was previously 

principal scientist at Capsugel’s Bend, Oregon facility.

Model-based formulation and technology selection methodologies facilitate rapid product development.


Selecting the Appropriate Technology for Oral Bioavailability Enhancement

Eli Lilly was awarded the 2017 FOYA Overall Winner for its continuous direct compression manufacturing installation projects.

Eli Lilly Wins 2017 Facility of the Year Award

The company has passed inspection by the UK Medicines and Healthcare products Regulatory Agency, and is now licensed to develop, manufacture, and pack non-potent and potent solid oral drug products at its site in Loughborough, England.

Almac Group’s UK Manufacturing Facilities Pass MHRA Inspection

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Support from FDA, a best practice guide, collaborative research, and new facilities signify progress in solid-dosage continuous manufacturing.  

Continuous Manufacturing Presses On

Continuous twin-screw granulation offers several options for increasing production scale. Thermo Fisher Scientific explains factors to consider in scale-up projects for manufacturing oral solid-dosage drugs. 

Solid/Semi-Solid Dosage